Skip to main content

Erectile Dysfunction Following Radical Prostatectomy

0
Pipeline Programs
3
Companies
4
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Comphya
ComphyaSwitzerland - Lausanne
2 programs
Activation of pro-erectile nerves within the pelvic plexusN/A1 trial
Activation of pro-erectile nerves within the pelvic plexusN/A1 trial
Active Trials
NCT05650866Recruiting20Est. Aug 2026
NCT06968494Recruiting20Est. Apr 2027
Dornier MedTech
Dornier MedTechFrance - Sillingy
1 program
Dornier Aries 2N/A1 trial
Active Trials
NCT03905057Unknown94Est. Jun 2021
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
RestoreX 1-6 monthsN/A1 trial
Active Trials
NCT05244486Recruiting200Est. Sep 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
ComphyaActivation of pro-erectile nerves within the pelvic plexus
ComphyaActivation of pro-erectile nerves within the pelvic plexus
UNION therapeuticsRestoreX 1-6 months
Dornier MedTechDornier Aries 2

Clinical Trials (4)

Total enrollment: 334 patients across 4 trials

NCT06968494ComphyaActivation of pro-erectile nerves within the pelvic plexus

Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction

Start: Jun 2025Est. completion: Apr 202720 patients
N/ARecruiting
NCT05650866ComphyaActivation of pro-erectile nerves within the pelvic plexus

Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction

Start: May 2023Est. completion: Aug 202620 patients
N/ARecruiting
NCT05244486UNION therapeuticsRestoreX 1-6 months

Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy

Start: Mar 2022Est. completion: Sep 2030200 patients
N/ARecruiting
NCT03905057Dornier MedTechDornier Aries 2

Early Shockwave Therapy for Post-RP ED

Start: Mar 2018Est. completion: Jun 202194 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 334 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.